GE Healthcare Technologies Inc
GEHC68.090USD
+0.020+0.03%
Handelsschluss 04/29, 16:00（ET）Kurse um 15 Minuten verzögert
31.11BMarktkapitalisierung
15.61KGV TTM
mehr Informationen über GE Healthcare Technologies Inc Unternehmen
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Unternehmensinformationen
Unternehmens-codeGEHC
Name des UnternehmensGE Healthcare Technologies Inc
IPO-datumDec 15, 2022
Gegründet am2022
CEOMr. Kevin Michael O'Neill
Anzahl der mitarbeiter53000
WertpapierartOrdinary Share
GeschäftsjahresendeDec 15
Addresse500 West Monroe Street
StadtCHICAGO
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl60661
Telefon18337351139
Websitehttps://www.gehealthcare.com
Unternehmens-codeGEHC
IPO-datumDec 15, 2022
Gegründet am2022
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1.93K%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
9.20K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
8.76K
--
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
8.76K
--
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
7.07K
--
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
6.02K
--
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
165.00
-86.19%
Mr. Lloyd W. Howell, Jr.
Mr. Lloyd W. Howell, Jr.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1.93K%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
9.20K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
8.76K
--
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
8.76K
--
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Total Imaging
8.86B
45.01%
Total Ultrasound
5.13B
26.08%
Total PCS
3.13B
15.89%
Total PDx
2.51B
12.75%
Other
52.00M
0.26%
Nach RegionUSD
Name
Umsatz
Anteil
Other
8.92B
45.34%
United States
8.62B
43.80%
China
2.13B
10.85%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Total Imaging
8.86B
45.01%
Total Ultrasound
5.13B
26.08%
Total PCS
3.13B
15.89%
Total PDx
2.51B
12.75%
Other
52.00M
0.26%
Aktionäre
Update-Zeit: Fri, Feb 21
Update-Zeit: Fri, Feb 21
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
Capital Research Global Investors
13.29%
The Vanguard Group, Inc.
11.43%
BlackRock Institutional Trust Company, N.A.
5.43%
State Street Global Advisors (US)
4.13%
Dodge & Cox
3.64%
Other
62.08%
Aktionärsstatistik
Aktionäre
Anteil
Capital Research Global Investors
13.29%
The Vanguard Group, Inc.
11.43%
BlackRock Institutional Trust Company, N.A.
5.43%
State Street Global Advisors (US)
4.13%
Dodge & Cox
3.64%
Other
62.08%
Art
Aktionäre
Anteil
Investment Advisor
40.35%
Investment Advisor/Hedge Fund
36.91%
Hedge Fund
3.13%
Research Firm
2.52%
Pension Fund
2.22%
Sovereign Wealth Fund
1.44%
Bank and Trust
1.32%
Insurance Company
0.36%
Individual Investor
0.27%
Other
11.47%
Institutionelle Beteiligung
Update-Zeit: Sun, Jan 19
Update-Zeit: Sun, Jan 19
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
2333
405.87M
88.75%
-9.18M
2024Q4
2344
405.16M
88.60%
-9.34M
2024Q3
2188
396.50M
86.79%
-11.03M
2024Q2
2081
391.61M
85.76%
-10.20M
2024Q1
2000
385.11M
84.39%
-2.29M
2023Q4
1855
385.99M
84.77%
-4.81M
2023Q3
1708
381.18M
83.73%
+1.51M
2023Q2
1574
374.50M
82.34%
-3.85M
2023Q1
1358
378.91M
83.35%
+182.70M
2022Q4
41
468.43M
103.20%
+468.43M
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Capital Research Global Investors
60.83M
13.3%
+2.61M
+4.48%
Dec 31, 2024
The Vanguard Group, Inc.
52.34M
11.45%
+2.16M
+4.30%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
24.86M
5.44%
+239.16K
+0.97%
Dec 31, 2024
State Street Global Advisors (US)
18.90M
4.13%
+281.45K
+1.51%
Dec 31, 2024
Dodge & Cox
16.68M
3.65%
+11.87K
+0.07%
Dec 31, 2024
Geode Capital Management, L.L.C.
11.32M
2.48%
+342.82K
+3.12%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
9.45M
2.07%
+126.88K
+1.36%
Feb 28, 2025
Norges Bank Investment Management (NBIM)
6.25M
1.37%
+1.84M
+41.76%
Dec 31, 2024
AllianceBernstein L.P.
6.13M
1.34%
-220.13K
-3.47%
Dec 31, 2024
Hotchkis and Wiley Capital Management, LLC
5.58M
1.22%
-18.35K
-0.33%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
Langar Global HealthTech ETF
10.47%
Invesco S&P Spin-Off ETF
7.54%
Otter Creek Focus Strategy ETF
4.86%
Absolute Select Value ETF
4.37%
iShares U.S. Medical Devices ETF
3.93%
Capital Group Dividend Value ETF
2.81%
VanEck Morningstar Wide Moat Value ETF
2.69%
VanEck Morningstar Wide Moat ETF
2.38%
VanEck Morningstar Wide Moat Growth ETF
1.99%
Themes US R&D Champions ETF
1.97%
Mehr Anzeigen
Langar Global HealthTech ETF
Anteil10.47%
Invesco S&P Spin-Off ETF
Anteil7.54%
Otter Creek Focus Strategy ETF
Anteil4.86%
Absolute Select Value ETF
Anteil4.37%
iShares U.S. Medical Devices ETF
Anteil3.93%
Capital Group Dividend Value ETF
Anteil2.81%
VanEck Morningstar Wide Moat Value ETF
Anteil2.69%
VanEck Morningstar Wide Moat ETF
Anteil2.38%
VanEck Morningstar Wide Moat Growth ETF
Anteil1.99%
Themes US R&D Champions ETF
Anteil1.97%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
96.00M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
Sep 22, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 15, 2023
Oct 19, 2023
Jun 23, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 15, 2023
Jul 20, 2023
Apr 25, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Jun 15, 2023 going ex on May 22, 2023
May 23, 2023
Jun 15, 2023
May 22, 2023
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten